- Home
- APGE vs MAN Comparison
APGE vs MAN Comparison
Compare APGE & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- MAN
- Stock Information
- Founded
- APGE 2022
- MAN 1948
- Country
- APGE United States
- MAN United States
- Employees
- APGE N/A
- MAN N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- MAN Professional Services
- Sector
- APGE Health Care
- MAN Consumer Discretionary
- Exchange
- APGE Nasdaq
- MAN Nasdaq
- Market Cap
- APGE 3.0B
- MAN 3.1B
- IPO Year
- APGE 2023
- MAN 1988
- Fundamental
- Price
- APGE $47.25
- MAN $61.72
- Analyst Decision
- APGE Strong Buy
- MAN Hold
- Analyst Count
- APGE 5
- MAN 6
- Target Price
- APGE $75.20
- MAN $76.60
- AVG Volume (30 Days)
- APGE 366.5K
- MAN 664.2K
- Earning Date
- APGE 11-12-2024
- MAN 10-17-2024
- Dividend Yield
- APGE N/A
- MAN 4.88%
- EPS Growth
- APGE N/A
- MAN N/A
- EPS
- APGE N/A
- MAN 0.78
- Revenue
- APGE N/A
- MAN $18,084,700,000.00
- Revenue This Year
- APGE N/A
- MAN N/A
- Revenue Next Year
- APGE N/A
- MAN $1.14
- P/E Ratio
- APGE N/A
- MAN $79.12
- Revenue Growth
- APGE N/A
- MAN N/A
- 52 Week Low
- APGE $16.39
- MAN $61.35
- 52 Week High
- APGE $72.29
- MAN $80.25
- Technical
- Relative Strength Index (RSI)
- APGE 35.00
- MAN 35.38
- Support Level
- APGE $57.85
- MAN $63.33
- Resistance Level
- APGE $63.50
- MAN $65.45
- Average True Range (ATR)
- APGE 3.86
- MAN 1.19
- MACD
- APGE -0.90
- MAN 0.12
- Stochastic Oscillator
- APGE 4.97
- MAN 7.09
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that includes Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives maximum of the company's revenue. The company derives maximum geographical revenue from Southern European region.